AUSTIN, Texas, Feb. 28 /PRNewswire-FirstCall/ -- Luminex Corporation (Nasdaq: LMNX), a leading multiplex solution developer, has signed a licensing agreement with the Massachusetts Institute of Technology (MIT) for non- exclusive intellectual property rights necessary to develop and commercialize microRNA assays and related products. MicroRNAs are a group of small non- coding single stranded portions of RNA molecules that have been implicated as playing a critical role as regulators of developmental timing, neuronal differentiation, cell proliferation, programmed cell death and fat metabolism. The rights and potential applications cover both the life science research and clinical diagnostics markets.